dual AChE inhibitors/CB1 antagonists (Solvay)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedual AChE inhibitors/CB1 antagonists (Solvay)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor antagonistsAcetylcholinesterase inhibitors
TargetsCannabinoid CB1 receptorAcetylcholinesterase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Healthcare Products Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Healthcare Products Bv
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A